Who
Ashoo Gupta
VP, Finance and Controller
Company insider
Files Form 4 as: VP, Finance and Controller, 4D Molecular Therapeutics.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $10K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Dec 2025
- Last trade
- 20 Mar 2026
- Last filed
- 24 Mar 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | —865 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,669310 at $8.61 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | —221 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —865 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —221 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Sold | $68980 at $8.61 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —865 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —221 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | —865 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,669310 at $8.61 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | —221 | filing |
| 20 Mar 2026filed 24 Mar 2026 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Sold | $68980 at $8.61 | filing |
| 20 Dec 2025filed 23 Dec 2025 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —866 at $0.00 | filing |
| 20 Dec 2025filed 23 Dec 2025 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —220 at $0.00 | filing |
| 20 Dec 2025filed 23 Dec 2025 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | —866 | filing |
| 20 Dec 2025filed 23 Dec 2025 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,691310 at $8.68 | filing |
| 20 Dec 2025filed 23 Dec 2025 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | —220 | filing |
| 20 Dec 2025filed 23 Dec 2025 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Sold | $68679 at $8.68 | filing |
News
Contrasting 4D Molecular Therapeutics (NASDAQ:FDMT) and Sangamo Therapeutics (NASDAQ:SGMO)FDMT · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Ashoo Gupta; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.